Journament

Keyword Connections - influenza Keywords

Connection Type	Connection
Journals	Heliyon zhonghua liu xing bing xue za zhi = zhonghua liuxingbingxue zazhi eLife BMC infectious diseases Journal of Asian natural products research gesundheitswesen (bundesverband der arzte des offentlichen gesundheitsdienstes (germany)) human vaccines & immunotherapeutics Indian journal of pediatrics nucleosides, nucleotides & nucleic acids health security clinical immunology (orlando, fla) value in health : the journal of the international society for pharmacoeconomics and outcomes research international journal of nursing studies journal of clinical anesthesia proceedings biological sciences Digital health Vaccine journal of the american association of nurse practitioners american journal of obstetrics and gynecology frontiers in neurology Preventive medicine reports the journal of law, medicine & ethics : a journal of the american society of law, medicine & ethics journal of infection and chemotherapy : official journal of the japan society of chemotherapy influenza and other respiratory viruses
Research Groups	No Research Group Connected
Bibliographies	[1] STEM: An Open Source Tool for Disease Modeling. [2] Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. [3] Health Equity, School Discipline Reform, and Restorative Justice. [4] Are social inequalities in influenza vaccination coverage in Japan reduced by health policy? [5] Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs. [6] Effects of temperature, humidity, and diurnal temperature range on influenza incidence in a temperate region. [7] Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study. [8] The effects of age on clinical characteristics, hospitalization and mortality of patients with influenza-related illness at a tertiary care centre in Malaysia. [9] Corrigendum to "Impact of the cognitive learning factors on sustainable organizational development" [Heliyon Volume 5, Issue 9, September 2019, e02398]. [10] Influenza. [11] Pharmacists' impact on older adults' access to vaccines in the United States. [12] Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. [13] Partnering with parents to remove barriers and improve influenza immunization rates for young children. [14] Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults. [15] Doctor YouTube's opinion on seasonal influenza: A critical appraisal of the information available to patients. [16] Predicting the short-term success of human influenza virus variants with machine learning. [17] Airway management and ventilation principles in COVID-19 patients. [18] Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 – 2016 [19] molecular characterization of severe and mild cases of influenza a (h1n1) 2009 strain from argentina caracterización molecular de cepas de influenza a (h1n1) 2009 de casos leves y graves de la argentina [20] the impact of altitude on hospitalization and hospital mortality from pandemic 2009 influenza a (h1n1) virus pneumonia in mexico el impacto de la altitud en las tasas de hospitalización y mortalidad por el virus de la influenza a (h1n1) pandémico en méxico [21] intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza [22] reacciones adversas a la vacuna contra influenza a (h1n1) en trabajadores de salud de una institución pública peruana [23] perfil epidemiológico de la mortalidad por influenza humana a (h1n1) en méxico epidemiological profile of mortality due to human influenza a (h1n1) in mexico [24] intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus [25] pandemic influenza vaccines – the challenges [26] in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections [27] ankara İli 2017 yılı 40. hafta ile 2018 yılı 20. hafta arasında yapılan sentinel İnfluenza benzeri hastalık (İbh) sürveyansının değerlendirilmesi [28] innate immunity induces the accumulation of lung mast cells during influenza infection [29] dendritic cells in innate and adaptive immune responses against influenza virus [30] encuesta nacional de cobertura de vacunación (influenza, neumococo y tétanos) en adultos mayores de 60 años en méxico national survey of vaccination coverage (influenza, pneumococcus and tetanus) in mexican population of 60 years of age and older [31] pseudotype-based neutralization assays for influenza: a systematic analysis [32] clinical and laboratory description of a series of cases of acute viral myositis [33] estudo sorológico sobre a cepa a/new jersey/8/76 em grupos populacionais brasileiros: nota prévia serologic study of the a/new jersey/8/76 influenza virus in brazilian population groups: communication [34] comparison of porcine airway and intestinal epithelial cell lines for the susceptibility and expression of pattern recognition receptors upon influenza virus infection [35] vacinação contra influenza e pneumococo na insuficiência cardíaca: uma recomendação pouco aplicada vacunación contra influenza y neumococo en la insuficiencia cardíaca: una recomendación poco aplicada influenza and pneumococcal vaccination in heart failure: a little applied recommendation [36] higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections [37] cytokine profiles of severe influenza virus-related complications in children [38] key ethical issues discussed at cdc-sponsored international, regional meetings to explore cultural perspectives and contexts on pandemic influenza preparedness and response [39] segurança, imunogenicidade e eficácia da vacina contra o vírus influenza em crianças safety, immunogenicity and efficacy of influenza vaccine in children [40] literature analysis of radiological studies on tuberculosis [41] viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza a(h7n9) virus in zhejiang, china, 2013 [42] characterization and epidemiology of influenza viruses in patients seeking treatment for influenza-like illnesses in rural bangladesh [43] influence of media on seasonal influenza epidemic curves [44] the end of the prohibition era: questions about injustice, effectiveness of laws and legalization of drugs [45] b cells and functional antibody responses to combat influenza [46] clinical advances in viral-vectored influenza vaccines [47] medical image of the week: bronchial clot removal via cryotherapy [48] knowledge, attitudes, and practices regarding pandemic h1n1 influenza among medical and dental residents and fellowships in shiraz, iran [49] association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: a population-based case-control study [50] the application of nhej-crispr/cas9 and cre-lox system in the generation of bivalent duck enteritis virus vaccine against avian influenza virus [51] síndrome de guillain-barré em associação temporal com a vacina influenza a guillain-barré syndrome in temporal association with influenza a vaccine [52] Design, synthesis and biological evaluation of honokiol derivatives as influenza neuraminidase inhibitors. [53] Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season [54] Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome [55] Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: A retrospective cohort study. [56] Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories. [57] Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity. [58] Poultry trading behaviours in Vietnamese live bird markets as risk factors for avian influenza infection in chickens. [59] Pandemic (H1N1) influenza in Diyarbakir, 2009 [60] Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017 [61] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017 [62] Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups [63] Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies [64] Drug resistance in influenza A virus: the epidemiology and management [65] Post-influenza aspergillosis, do not underestimate influenza B [66] Peramivir injection in the treatment of acute influenza: a review of the literature [67] Modeling human influenza infection in the laboratory [68] Influenza treatment and prophylaxis with neuraminidase inhibitors: a review [69] Current management of parainfluenza pneumonitis in immunocompromised patients: a review [70] Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public [71] Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST) [72] Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase [73] Influenza A Viral Infection with Septic Shock in Pregnancy [74] Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017 [75] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017 [76] Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups [77] Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies [78] Drug resistance in influenza A virus: the epidemiology and management [79] Post-influenza aspergillosis, do not underestimate influenza B [80] Peramivir injection in the treatment of acute influenza: a review of the literature [81] Modeling human influenza infection in the laboratory [82] Influenza treatment and prophylaxis with neuraminidase inhibitors: a review [83] Current management of parainfluenza pneumonitis in immunocompromised patients: a review [84] Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public [85] Isolation and Antibiotic Susceptibility Testing of Haemophilus influenzae from Nasopharynx of Children under Five Years Attending Maternal and Child Health Clinic in Mbarara Regional Referral Hospital [86] Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia. [87] Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department. [88] Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient [89] Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China. [90] Observer-Based Adaptive PI Sliding Mode Control of Developed Uncertain SEIAR Influenza Epidemic Model Considering Dynamic Population. [91] Editorial: Epidemiology of Avian Influenza Viruses. [92] Protection of wetlands as a strategy for reducing the spread of avian influenza from migratory waterfowl. [93] Polygalasaponin F treats mice with pneumonia induced by influenza virus. [94] A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice [95] Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans. [96] A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age. [97] Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay [98] A qualitative study of pandemic influenza preparedness among small and medium-sized businesses in New York City. [99] Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis. [100] CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases [101] Health information technology use and influenza vaccine uptake among US adults.